Skip to main content

Plaintiffs Fight Against The Mass Removal Of Talc Lawsuit

Plaintiffs Fight Against The Mass Removal Of Talc Lawsuit

Plaintiffs Fight Against The Mass Removal Of Talc Lawsuit

Introduction

Johnson & Johnson faced opposition from plaintiffs attorneys to push back against the mass removal of their cases from state to federal court following the bankruptcy filed by Imerys Inc., J&J’s major talc supplier. The lawyers represent hundreds of women who allege talcum powder caused their ovarian cancer.

Nancy Winkler of Eisenberg Rothweiler Winkler Eisenberg & Jeck is representing several plaintiffs. In one of the cases handled by Winkler for Ellen Kleiner, the trial was cleared to be Philadelphia’s first trial over the alleged link between talc and ovarian cancer, but the case was removed in April, for the second time, to federal court in Pennsylvania. Winkler filed a motion for remand and said she is preparing to try the case in Philadelphia state court in early 2020.

Nearly 14,000 talcum powder lawsuits are filed against J&J, each raising a common allegation that asbestos exposure from the company’s talc-based products causes ovarian cancer or mesothelioma. Hon. Freda L. Wolfson, U.S.D.J./ Hon. Lois H. Goodman, U.S.M.J. overlooks J&J's talcum powder multidistrict litigation (MDL No. 2738; In Re: Johnson & Johnson Talcum Powder Products Marketing, Sales Practices, and Products Liability Litigation) in the District of New Jersey.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

Cencora Directors Settle Opioid Oversight Case for $111M

Categories: Opioids

Cencora has agreed to pay $111.3 million to settle a shareholder lawsuit accusing the company’s directors of failing to prevent the unlawful distribution of opioids

Study Finds CPAP May Harm Low-Risk Sleep Apnea Patients

A new study has cast doubt on the long-standing belief that continuous positive airway pressure (CPAP) machines significantly reduce heart…

FDA Adds New Warnings on Long-Term Opioid Risks

Categories: Opioids

Federal regulators have raised concerns that many opioid medications were approved for prolonged use without sufficient clinical evidence confirming their safety.

✍️ FREE — 2,800 Pages Legal Process Outsourcing Trial!                 
No Contract. No Risk — Full Mass Tort + LPO Access, Free!

Only 10 Firms Accepted—Offer Ends August 31!